China SC Index (HAO)

[glens0]

$HAO Haoxi Health Technology sees FY24 revenue $48.52M vs. $28.23M last year

HAO projects revenue growth during FY24, which it attributes to the Company's strategic development in online advertising solutions, particularly through short video formats and news feed ads. The Company's proprietary data analysis software, Bidding Compass, enables it to optimize ad placements, which it believes has driven growth in both revenue and profit for FY24. Gross Profit: Approximately $2.75 million for FY24, reflecting a 33.4% increase from $2.06 million in FY23. Net Income: Approximately $1.29 million for FY24, reflecting a 33.2% increase from $0.97 million in FY23.

Total Assets: As of June 30, 2024, the Company's total assets increased to approximately $15.51 million, from $4.46 million at the end of FY23, reflecting HAO's operational scale and capital utilization after its initial public offering. "We believe that our preliminary FY24 results reflect the strength of our business model and our team's ability to navigate through a rapidly evolving online advertising landscape," said Mr. Zhen Fan, CEO of the Company. "Our dedicated team, coupled with our focus on the healthcare sector, has enabled us to consistently deliver value to our clients. We look forward to maintaining this momentum as we continue to expand our partnerships and enhance our service offerings."